APA (7th ed.) Citation

C, Z., X, Z., L, L., T, M., M, S., Y, Y., & Q, F. (2019). A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Zhang, Zhu X, Li L, Ma T, Shi M, Yang Y, and Fan Q. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.

MLA (8th ed.) Citation

C, Zhang, et al. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.